My research focuses on the intersection of molecular biology, cancer therapeutics, and nanotechnology, with an emphasis on the development of plant-based nanomaterials for biomedical applications. Specifically, I investigate the green synthesis of metal nanoparticles (such as gold, silver, and nanodiamonds) using bioactive compounds derived from medicinal plants to enhance their anticancer and antibacterial properties.

I am also interested in molecular mechanisms of carcinogenesis, including gene expression regulation, hypoxia pathways, and autophagy-related signaling, to understand how natural products and nanoformulations modulate these processes. My current projects involve the design and evaluation of nanoparticle-based delivery systems for compounds such as tetrahydrocurcumin, quercetin, and annonaceous acetogenins, aimed at improving their selectivity and therapeutic efficacy against breast and colon cancers.

In addition, my research integrates bioinformatics, proteomics, and transcriptomic profiling to decode molecular responses in cancer cells treated with nanomedicine-based formulations. This multidisciplinary approach bridges cell biology, chemistry, and computational biology to advance the development of sustainable, targeted, and effective nanotherapeutics.